Loading Tct2025Hero...
The 5th Annual THT:
Technology and Heart Failure Therapeutics™ Conference
Pioneering Innovations in Heart Failure Therapies
Since its debut in 2022, THT™ has delivered an immersive experience in heart failure innovation, focusing on device- and technology-based treatments within the context of drug therapies. Sponsored by the Cardiovascular Research Foundation® (CRF®), THT brings global leaders together to drive transformative advances and improve patient outcomes.
What’s New at THT™ 2026?
NEW LVAD TECHNOLOGIES
Deep dives into the latest surge of innovation
CARDIAC XENOTRANSPLANT
New insights that build on recent successes in renal transplant
AND MORE TO COME AS THE PROGRAM DEVELOPS!
Your THT™ 2026:
Heart Failure, Technology, and the Future
Loading Tct2025GradBg...
Who Should Attend THT 2026?
THT 2026 is designed for a multidisciplinary audience interested in heart failure management and a comprehensive overview of current and emerging interventions, including:
Physicians and Fellows
- Heart failure specialists (fellows, nurses, physicians, and research coordinators).
- Cardiac imaging specialists.
- Cardiac and vascular surgeons.
- Clinical cardiologists.
- Fellows in interventional cardiovascular medicine and related fields.
- Interventional cardiologists.
Allied Health Professionals
- Nurse practitioners.
- Physician assistants.
- Research assistants.
- Research scientists.
- Other health care professionals.
Industry Professionals
- Medical device experts.